Effectiveness and safety of beclomethasone dipropionate, an intranasal corticosteroid, in the treatment of patients with allergic rhinitis
- 1 November 1995
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 17 (6) , 1032-1041
- https://doi.org/10.1016/0149-2918(95)80082-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mediators of allergic rhinitisJournal of Allergy and Clinical Immunology, 1992
- Fluticasone propionate given once daily is as effective for seasonal allergic rhinitis as beclomethasone dipropionate given twice dailyJournal of Allergy and Clinical Immunology, 1992
- Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthmaJournal of Allergy and Clinical Immunology, 1992
- Different Effects of Nasal and Bronchial Glucocorticosteroid Administration on Bronchial Hyperresponsiveness in Patients with Allergic RhinitisAmerican Review of Respiratory Disease, 1992
- Effect of Topical Corticosteroids on the Recovery of Histamine Releasing Factors in Nasal Washings of Patients with Allergic Rhinitis: A Double-blind, Randomized, Placebo-controlled StudyAmerican Review of Respiratory Disease, 1992
- Allergic rhinitisPostgraduate Medicine, 1992
- The pathophysiology of rhinitis: V. Sources of protein in allergen-induced nasal secretionsJournal of Allergy and Clinical Immunology, 1991
- Clinical, rhinomanometric, and cytologic evaluation of seasonal allergic rhinitis treated with beclomethasone dipropionate as aqueous nasal spray or pressurized aerosolJournal of Allergy and Clinical Immunology, 1986
- Beclomethasone Dipropionate A Reappraisal of its Pharmacodynamic Properties and Therapeutic Efficacy After a Decade of Use in Asthma and RhinitisDrugs, 1984
- Local Effect of Intranasal Beclomethasone Dipropionate Aerosol in Hay FeverBMJ, 1973